<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>immuno-oncology | CSE Tracker</title>
    <link>https://master--youthful-lamport-190a0e.netlify.app/tag/20211019immuno-oncology/</link>
      <atom:link href="https://master--youthful-lamport-190a0e.netlify.app/tag/20211019immuno-oncology/index.xml" rel="self" type="application/rss+xml" />
    <description>immuno-oncology</description>
    <generator>Wowchemy (https://wowchemy.com)</generator><language>en-us</language><lastBuildDate>Tue, 19 Oct 2021 10:00:00 -0700</lastBuildDate>
    <image>
      <url>https://master--youthful-lamport-190a0e.netlify.app/images/icon_hua2ec155b4296a9c9791d015323e16eb5_11927_512x512_fill_lanczos_center_2.png</url>
      <title>immuno-oncology</title>
      <link>https://master--youthful-lamport-190a0e.netlify.app/tag/20211019immuno-oncology/</link>
    </image>
    
    <item>
      <title>Treatment-free Survival as a Novel Outcome Measure of Immuno-oncology-based Therapy</title>
      <link>https://master--youthful-lamport-190a0e.netlify.app/webinar/20211019treatment-free-survival/</link>
      <pubDate>Tue, 19 Oct 2021 10:00:00 -0700</pubDate>
      <guid>https://master--youthful-lamport-190a0e.netlify.app/webinar/20211019treatment-free-survival/</guid>
      <description>&lt;p&gt;&lt;em&gt;Frontiers in Biostatistics by Dana-Farber Cancer Institute&lt;/em&gt;&lt;/p&gt;</description>
    </item>
    
  </channel>
</rss>
